Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Array-based resequencing assay for mutations causing hypertrophic cardiomyopathy.

Stephan Waldmüller1, Melanie Müller, Kirsten Rackebrandt

  • 1Institute for Heart and Circulation Research, University of Witten/Herdecke, Dortmund, Germany. waldmueller@herz-kreislaufforschung.de

Clinical Chemistry
|February 9, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Controlling electron transfer channels in a plasmonic scanning tunneling microscope junction under light excitation.

Nanoscale·2026
Same author

Combining space use with diet data to investigate foraging tactics of black bears in response to the pulsed availability of migratory caribou calves.

PloS one·2026
Same author

Broadening SARS-CoV-2 Immunity by Combining ORFV and Protein-Based Vaccines.

Vaccines·2026
Same author

Heterologous ORFV-Ad26 vaccination broadens antibody breadth and amplifies cellular immunity against SARS-CoV-2 spike.

Frontiers in immunology·2025
Same author

Heterologous prime-boost vaccination with VLA2001 and an ORFV-based vector enhances spike- and nucleocapsid-specific immunity in mice.

Frontiers in immunology·2025
Same author

Orf virus-based vectors induce potent germinal center B cell, Tfh cell, and CD8<sup>+</sup> T cell responses.

Molecular therapy : the journal of the American Society of Gene Therapy·2025
Same journal

Interlaboratory Comparison of a Glucagon and Oxyntomodulin Immuno-LC-MS/MS Assay: Implications for Diabetes Research.

Clinical chemistry·2026
Same journal

Comparison of Information-Dependent Acquisition and Sequential Window Acquisition of All Theoretical Mass Spectra for Untargeted Drug Testing on a Linear Ion Trap-Pulsing Quadrupole-Time of Flight Mass Spectrometer.

Clinical chemistry·2026
Same journal

Patterns of One-Year Change in HbA1c and Continuous Glucose Monitoring (CGM) Metrics in Older Adults with Type 2 Diabetes.

Clinical chemistry·2026
Same journal

TSH Pediatric Reference Intervals: Lack of CALIPER Applicability to US-Based Populations.

Clinical chemistry·2026
Same journal

Rapid Detection of Hemoglobinopathy Variants Using One-Step Library Preparation and Nanopore Sequencing.

Clinical chemistry·2026
Same journal

Editor's Note: Circulating Proteolytic Products of Carboxypeptidase N for Early Detection of Breast Cancer.

Clinical chemistry·2026
See all related articles

An array-based resequencing assay was developed for hypertrophic cardiomyopathy (HCM) genetic testing. This method efficiently identifies mutations, reducing workload and aiding large-scale genetic and phenotypic diversity studies in cardiovascular disease.

Area of Science:

  • Cardiovascular Genetics
  • Molecular Diagnostics

Background:

  • Hypertrophic cardiomyopathy (HCM) is the most prevalent genetic cardiovascular disease.
  • Understanding its genetic basis is crucial for management and research.
  • Genetic testing for HCM is complex and labor-intensive.

Purpose of the Study:

  • To develop and evaluate an array-based resequencing (ABR) assay for genetic testing in HCM.
  • To assess the efficiency and accuracy of ABR compared to conventional methods.

Main Methods:

  • Development of an Affymetrix resequencing array.
  • Utilized a single long-range PCR protocol.
  • Targeted the three most commonly affected genes in HCM: MYH7, MYBPC3, and TNNT2.

Main Results:

Related Experiment Videos

  • The ABR assay detected the underlying point mutation in 23 of 24 reference samples.
  • Achieved >99.9% comparability with conventional capillary sequencing.
  • Identified one heterozygous variant missed by each respective method.

Conclusions:

  • ABR significantly reduces the workload associated with HCM genetic testing.
  • The HCM array facilitates large-scale studies on HCM genetic and phenotypic diversity.
  • This assay can advance understanding of HCM and related cardiomyopathies.